Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 35.34 M33.7 M28.26 M30.77 M 128.07 M Research & development ———— — Operating income 38.67 M33.94 M22.56 M23.46 M 118.63 M Non-Operating Income, Total 2.85 M1.44 M917 K-1.14 M 4.07 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 1.43 M722 K458 K-568 K 2.04 M Unusual income/expense 1.43 M721 K459 K-568 K 2.04 M Pretax income 279.3 M245.77 M214.78 M212.78 M 952.63 M Equity in earnings ———— — Taxes 9.07 M8.23 M5.27 M4.46 M 27.03 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 28.25 M22.6 M14.31 M15.46 M 80.63 M Discontinued operations ———— — Net income 28.25 M22.6 M14.31 M15.46 M 80.63 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 28.25 M22.6 M14.31 M15.46 M 80.63 M Basic earnings per share (Basic EPS) 1.361.090.690.74 3.88 Diluted earnings per share (Diluted EPS) 1.351.080.690.74 3.86 Average basic shares outstanding 20.78 M20.74 M20.74 M20.74 M — Diluted shares outstanding 20.85 M20.85 M20.84 M20.86 M — EBITDA 51.58 M46.24 M34.93 M14.68 M 147.43 M EBIT 37.63 M32.98 M21.52 M1.1 M 93.23 M Cost of revenue 241.67 M212.79 M193.27 M211.67 M 859.4 M Other cost of goods sold 220.91 M212.79 M193.27 M— — Depreciation & amortization (cash flow) 13.95 M13.26 M13.41 M13.58 M 54.2 M